NASDAQ:AVXL

Anavex Life Sciences Stock Predictions

Healthcare > Biotechnology

Buy AVXL

*Your capital is at risk

$2.65

-0.140 (-5.03%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

AVXL Prediction Chart

AVXL Predictions History

Latest community submissions for AVXL.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
StockInvest Amateur	Aug 15, 2016	$3.94 +11.30%	$3.54	X	88.70%	0
Omar.ramirez.137	Apr 28, 2016	$5.72 +2.88%	$5.56	X	97.10%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AVXL with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ANAVEX LIFE SCIENCES CORP.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by